FHL1

From Wikipedia, the free encyclopedia


Four and a half LIM domains 1
PDB rendering based on 1x63.
Available structures: 1x63, 2cup, 2cur
Identifiers
Symbol(s) FHL1; FHL1B; KYO-T; MGC111107; SLIM1; bA535K18.1
External IDs OMIM: 300163 MGI1298387 HomoloGene31038
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 2273 14199
Ensembl ENSG00000022267 ENSMUSG00000023092
Uniprot Q13642 P97447
Refseq NM_001449 (mRNA)
NP_001440 (protein)
NM_001077361 (mRNA)
NP_001070829 (protein)
Location Chr X: 135.06 - 135.12 Mb Chr X: 53.08 - 53.14 Mb
Pubmed search [1] [2]

Four and a half LIM domains 1, also known as FHL1, is a human gene.[1]

LIM proteins, named for 'LIN11, ISL1, and MEC3,' are defined by the possession of a highly conserved double zinc finger motif called the LIM domain.[supplied by OMIM][1]

[edit] References

[edit] Further reading

  • Morgan MJ, Madgwick AJ, Charleston B, et al. (1995). "The developmental regulation of a novel muscle LIM-protein.". Biochem. Biophys. Res. Commun. 212 (3): 840–6. doi:10.1006/bbrc.1995.2045. PMID 7626119. 
  • Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.". Gene 138 (1-2): 171–4. PMID 8125298. 
  • Morgan MJ, Madgwick AJ (1996). "Slim defines a novel family of LIM-proteins expressed in skeletal muscle.". Biochem. Biophys. Res. Commun. 225 (2): 632–8. doi:10.1006/bbrc.1996.1222. PMID 8753811. 
  • Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library.". Gene 200 (1-2): 149–56. PMID 9373149. 
  • Lee SM, Tsui SK, Chan KK, et al. (1998). "Chromosomal mapping, tissue distribution and cDNA sequence of four-and-a-half LIM domain protein 1 (FHL1).". Gene 216 (1): 163–70. PMID 9714789. 
  • Tani S, Taniwaki M, Taniguchi Y, et al. (1999). "Chromosomal mapping of two RBP-J-related genes: Kyo-T and RBP-L.". J. Hum. Genet. 44 (1): 73–5. PMID 9929984. 
  • Morgan MJ, Madgwick AJ (1999). "The LIM proteins FHL1 and FHL3 are expressed differently in skeletal muscle.". Biochem. Biophys. Res. Commun. 255 (2): 245–50. doi:10.1006/bbrc.1999.0179. PMID 10049693. 
  • Greene WK, Baker E, Rabbitts TH, Kees UR (1999). "Genomic structure, tissue expression and chromosomal location of the LIM-only gene, SLIM1.". Gene 232 (2): 203–7. PMID 10352231. 
  • Brown S, McGrath MJ, Ooms LM, et al. (1999). "Characterization of two isoforms of the skeletal muscle LIM protein 1, SLIM1. Localization of SLIM1 at focal adhesions and the isoform slimmer in the nucleus of myoblasts and cytoplasm of myotubes suggests distinct roles in the cytoskeleton and in nuclear-cytoplasmic communication.". J. Biol. Chem. 274 (38): 27083–91. PMID 10480922. 
  • Lee SM, Li HY, Ng EK, et al. (1999). "Characterization of a brain-specific nuclear LIM domain protein (FHL1B) which is an alternatively spliced variant of FHL1.". Gene 237 (1): 253–63. PMID 10524257. 
  • Ng EK, Lee SM, Li HY, et al. (2001). "Characterization of tissue-specific LIM domain protein (FHL1C) which is an alternatively spliced isoform of a human LIM-only protein (FHL1).". J. Cell. Biochem. 82 (1): 1–10. PMID 11400158. 
  • Lange S, Auerbach D, McLoughlin P, et al. (2003). "Subcellular targeting of metabolic enzymes to titin in heart muscle may be mediated by DRAL/FHL-2.". J. Cell. Sci. 115 (Pt 24): 4925–36. PMID 12432079. 
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932. 
  • Gevaert K, Goethals M, Martens L, et al. (2004). "Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides.". Nat. Biotechnol. 21 (5): 566–9. doi:10.1038/nbt810. PMID 12665801. 
  • McGrath MJ, Mitchell CA, Coghill ID, et al. (2004). "Skeletal muscle LIM protein 1 (SLIM1/FHL1) induces alpha 5 beta 1-integrin-dependent myocyte elongation.". Am. J. Physiol., Cell Physiol. 285 (6): C1513–26. doi:10.1152/ajpcell.00207.2003. PMID 12917103. 
  • Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039. 
  • Qin H, Wang J, Liang Y, et al. (2004). "RING1 inhibits transactivation of RBP-J by Notch through interaction with LIM protein KyoT2.". Nucleic Acids Res. 32 (4): 1492–501. doi:10.1093/nar/gkh295. PMID 14999091. 
  • Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334. 
  • Philippar U, Schratt G, Dieterich C, et al. (2005). "The SRF target gene Fhl2 antagonizes RhoA/MAL-dependent activation of SRF.". Mol. Cell 16 (6): 867–80. doi:10.1016/j.molcel.2004.11.039. PMID 15610731. 
  • Qin H, Du D, Zhu Y, et al. (2005). "The PcG protein HPC2 inhibits RBP-J-mediated transcription by interacting with LIM protein KyoT2.". FEBS Lett. 579 (5): 1220–6. doi:10.1016/j.febslet.2005.01.022. PMID 15710417. 

[edit] External links


This article incorporates text from the United States National Library of Medicine, which is in the public domain.